Misato Irie
Overview
Explore the profile of Misato Irie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masaki K, Suzukawa M, Sasano H, Harada N, Miyazaki Y, Katsura H, et al.
Allergol Int
. 2024 Dec;
PMID: 39632158
Background: Biologics are integral in the management of severe asthma. As the effectiveness of the anti-IL-5 receptor antibody benralizumab in Japan remains elusive, this study aimed to assess its real-world...
2.
Irie M, Kabata H, Fukunaga K
STAR Protoc
. 2024 Jan;
5(1):102854.
PMID: 38294912
Modifying gene expression in lymphocytes is essential for immunological research; however, gene transfection methods for group 2 innate lymphoid cells (ILC2s) are not well established. Here, we present a protocol...
3.
Terai H, Ishii M, Takemura R, Namkoong H, Shimamoto K, Masaki K, et al.
Respir Investig
. 2023 Oct;
61(6):802-814.
PMID: 37783167
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly since 2019, and the number of reports regarding long COVID has increased. Although the distribution of long COVID depends...
4.
Baba R, Kabata H, Shirasaki Y, Kamatani T, Yamagishi M, Irie M, et al.
J Allergy Clin Immunol Glob
. 2023 Oct;
1(4):299-304.
PMID: 37779537
Background: Group 2 innate lymphoid cells (ILC2s) produce type 2 cytokines by stimulation with epithelial cell-derived cytokines and are implicated in the pathogenesis of various allergic diseases, including asthma. However,...
5.
Tanaka Y, Yamagishi M, Motomura Y, Kamatani T, Oguchi Y, Suzuki N, et al.
Commun Biol
. 2023 Sep;
6(1):915.
PMID: 37673922
The decision of whether cells are activated or not is controlled through dynamic intracellular molecular networks. However, the low population of cells during the transition state of activation renders the...
6.
Irie M, Kabata H, Sasahara K, Kurihara M, Shirasaki Y, Kamatani T, et al.
Cell Rep
. 2023 Jun;
42(6):112610.
PMID: 37294636
Group 2 innate lymphoid cells (ILC2s) produce large amounts of type 2 cytokines including interleukin-5 (IL-5) and IL-13 in response to various stimuli, causing allergic and eosinophilic diseases. However, the...
7.
Kurihara M, Masaki K, Matsuyama E, Fujioka M, Hayashi R, Tomiyasu S, et al.
Biomolecules
. 2022 Dec;
12(12).
PMID: 36551171
Reports of eosinophilic pneumonia (EP) as a side effect of dupilumab administration are limited in previous studies. Herein, we report two cases in which EP developed subsequent to the administration...
8.
Kurihara M, Kabata H, Irie M, Fukunaga K
Allergol Int
. 2022 Dec;
72(1):24-30.
PMID: 36470789
Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that plays a vital role in the induction of type 2 inflammation via both innate and acquired immune cascades. Tezepelumab, a...
9.
Irie M, Sasahara K, Artis D, Kabata H
Allergol Int
. 2022 Apr;
71(3):294-300.
PMID: 35367135
The neural and immune systems are closely connected, and recently, their molecular mechanisms and relationships with diseases have attracted substantial attention. Particularly, it has been increasingly reported that ILC2s, which...
10.
Okuzumi S, Miyata J, Kabata H, Mochimaru T, Kagawa S, Masaki K, et al.
Am J Respir Cell Mol Biol
. 2021 May;
65(3):309-318.
PMID: 34003734
Group 2 innate lymphoid cells (ILC2s) play an important role in the pathophysiology of asthma via the robust production of type 2 cytokines. Recent studies have demonstrated that TLR7 (Toll-like...